Stroke Blood Test Work Published New Test Helps Doctors Predict and Prevent Stroke
October 17, 2011
Decatur, GA -- DeKalb Medical is pleased to announce that the work of Neurologist Joseph D. Weissman, M.D., Ph.D., has been published in the Journal of Neurological Sciences, a peer-reviewed medical journal. NR2 antibodies: Risk assessment of transient ischemic attack (TIA)/stroke in patients with history of isolated and multiple cerbrovascular events appears in the January 2011 edition of the Journal of Neurological Sciences.
The article details Dr. Weissman's research in developing a blood test to predict a patient's risk of stroke, and was co-authored by research partners at DeKalb Medical including Laboratory Administrative Director, Roslyn Heath, M.B.A., M.T.(ASCP), and others at several academic research institutions throughout the United States including Kennesaw State University's Dr. Svetlana Dambinova. "Predicting stroke using biomarkers would enable clinicians to help prevent stroke or mitigate damage. Several stroke biomarkers have been investigated but none has shown near term predictive value." said Dr. Weissman.
In addition to measuring stroke risk, the antibody biomarker test allows clinicians to learn more about stroke function, including insight into the rate of acute infarction (heart attack) and determining the number of strokes a patient has already experienced. The antibody biomarker test is CLIA-approved although not yet FDA-approved, and costs from $25 to $50, as compared to an MRI which can cost up to $5,000.
About DeKalb Medical
With more than 800 doctors skilled in 55 medical specialties, DeKalb Medical combines cutting-edge technology with compassion to effectively diagnose and treat our patients. A leader in cancer, heart attack treatment and orthopedics, our non-profit health system and DeKalb Medical Physicians have been growing with metro-Atlanta’s medical needs since 1961.
More than just a provider of hospital services, DeKalb Medical has helped usher in a new era of electronic medical records that puts information at your doctor’s fingertips for improved patient safety and outcomes. Our 627-bed system includes DeKalb Medical at North Decatur (451 beds), DeKalb Medical Long Term Acute Care at Downtown Decatur (76 beds) and DeKalb Medical at Hillandale (100 beds). Committed to pushing beyond to excel in patient satisfaction and service, our quality is reflected in many clinical excellence awards throughout our three-hospital system including recently ranking in the Top 5% in the Nation for Overall Orthopedic Services by HealthGrades® (2011).
Media Contact: Tori Vogt MBA
firstname.lastname@example.org / 404.501.2885